1. Home
  2. MOLN vs EXFY Comparison

MOLN vs EXFY Comparison

Compare MOLN & EXFY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MOLN
  • EXFY
  • Stock Information
  • Founded
  • MOLN 2004
  • EXFY 2008
  • Country
  • MOLN Switzerland
  • EXFY United States
  • Employees
  • MOLN N/A
  • EXFY N/A
  • Industry
  • MOLN
  • EXFY Computer Software: Prepackaged Software
  • Sector
  • MOLN
  • EXFY Technology
  • Exchange
  • MOLN Nasdaq
  • EXFY Nasdaq
  • Market Cap
  • MOLN 218.1M
  • EXFY 241.7M
  • IPO Year
  • MOLN 2021
  • EXFY 2021
  • Fundamental
  • Price
  • MOLN $5.31
  • EXFY $2.75
  • Analyst Decision
  • MOLN Hold
  • EXFY Buy
  • Analyst Count
  • MOLN 1
  • EXFY 4
  • Target Price
  • MOLN $4.50
  • EXFY $2.83
  • AVG Volume (30 Days)
  • MOLN 40.7K
  • EXFY 713.0K
  • Earning Date
  • MOLN 08-26-2024
  • EXFY 11-07-2024
  • Dividend Yield
  • MOLN N/A
  • EXFY N/A
  • EPS Growth
  • MOLN N/A
  • EXFY N/A
  • EPS
  • MOLN N/A
  • EXFY N/A
  • Revenue
  • MOLN $7,105,397.00
  • EXFY $137,440,000.00
  • Revenue This Year
  • MOLN N/A
  • EXFY N/A
  • Revenue Next Year
  • MOLN $29.41
  • EXFY $7.39
  • P/E Ratio
  • MOLN N/A
  • EXFY N/A
  • Revenue Growth
  • MOLN N/A
  • EXFY N/A
  • 52 Week Low
  • MOLN $3.32
  • EXFY $1.24
  • 52 Week High
  • MOLN $12.70
  • EXFY $3.00
  • Technical
  • Relative Strength Index (RSI)
  • MOLN 45.05
  • EXFY 73.76
  • Support Level
  • MOLN $5.67
  • EXFY $1.82
  • Resistance Level
  • MOLN $6.24
  • EXFY $2.97
  • Average True Range (ATR)
  • MOLN 0.37
  • EXFY 0.18
  • MACD
  • MOLN -0.11
  • EXFY 0.11
  • Stochastic Oscillator
  • MOLN 12.58
  • EXFY 79.58

About MOLN Molecular Partners AG

Molecular Partners AG is a clinical stage biopharmaceutical company. The Company has programs in various stages of pre-clinical and clinical development, with oncology as its main focus. The firm develops protein therapeutics called DARPin therapeutics for the treatment of serious diseases, including cancer and sight-threatening disorders. The company's product pipeline is organized principally through three areas: Ophthalmology, including the creation of therapies for retinal diseases like wet age-related macular degeneration and diabetic macular edema; the Oncology pipeline comprises DARPin candidates with novel modes of action, including multi-DARPin compounds; and Immuno-oncology for anticancer treatment.

About EXFY Expensify Inc.

Expensify Inc is a cloud-based expense management software platform that helps various businesses simplify the way to manage money. It is used to scan and reimburse receipts from flights, hotels, coffee shops, office supplies and ride shares. People use Expensify's free features, which include corporate cards, expense tracking, next-day reimbursement, invoicing, bill pay, and travel booking in one app.

Share on Social Networks: